Defence is the Best Attack: Immuno-Oncology Breakthroughs
Laura Strachan: l.strachan@nottingham.ac.uk
This new conference to be held in Barcelona, Spain, features an outstanding, internationally renowned faculty who will discuss their up-to-the-minute findings as well as roadmap the 'where to' in identifying novel targets, progressing our understanding of the mechanisms of action of therapeutic interventions, developing improved biomarkers of response to therapy, and overcoming mechanisms of intrinsic and acquired resistance to immunotherapy. With extensive networking opportunities, this conference will provide an intimate setting for top quality scientific interaction. Who should attend? The target audience for this conference is basic and translational scientists and clinicians, both senior and young investigators that want to have a broad and detailed overview of the most recent advances in the field of immunotherapy.
